Methylprednisolone Acetate

醋酸甲泼尼龙

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameMethylprednisolone Acetate
Drug Alias Name甲基强的松龙乙酸酯Methylprednisolone acetate esterM-predrolDepo-medrolDepo-Medrone +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsChronic PainPainHypersensitivity +[29] 
Global Approved IndicationsHypersensitivityAddison DiseaseHypercalcemia +[26] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1958/03/01
Country/TerritoryUnited StatesNetherlandsEgypt +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesUtah State UniversityPfizer IncPfizer Japan Inc +[4] 
Inactive CompaniesAssiut University
Active IndicationsPainHypersensitivityAddison Disease +[28] 
Inactive IndicationsChronic Pain

Other Information

ATC CodeD07AA01D10AA02H02AB04
Related LinksWikipediaDrugBankKEGG